Step-by-step Individual Intensification of Therapy for Type 2 Diabetes Mellitus. What is Further Choice after Metformin? (Literature Review)
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 2, Issue 66
Abstract
Metformin — first-line drug for the treatment of diabetes mellitus (DM) type 2, the use of which reduces the progression of carbohydrate metabolism disorders and helps to reduce mortality rates. The progressive course of DM type 2 leads to the fact that patients, in which initial therapy contained only metformin, ultimately required step-by-step addition of other glucose-lowering drugs to achieve and maintain glycemic control. This literature review examines different approaches to step-by-step individual intensification of therapy for DM type 2. The most popular and most studied combination aimed at both defects determining the development of metabolic disorders in DM type 2 (relative insulin deficiency and insulin resistance) is a combination of metformin with sulfonylurea agents. Glimepiride has a unique combination of insulin secretagogue («careful» stimulation) and insulin sensitizing properties at neutral effect on body weight and lower the risk of hypoglycemia. Therefore, glimepiride today is regarded as the best choice in patients with DM type 2 in the presence of cardiovascular risk compared with other sulfonylurea drugs.
Authors and Affiliations
І. V. Pankiv
Case of Combination of Hyperprolactinemic Hypogonadism and Mosaic Turner Syndrome
After detail examination of 24-year-old female patient (cariotype — 46XX/45XO, sex chromatin — 11 %, serum prolactin level — more than 200 mIU/ml (normal level — less than 26,72), ovarian ultrasound, geneticist consu...
Management of Diabetic Neuropathy: Focus on Patient
The article highlights the questions of pathogenesis and treatment of diabetic neuropathy — one of the most frequent complications of diabetes mellitus. The effects of alpha-lipoic acid — first-line drug in the treatment...
Morphometric and Biochemical Clusters of Metabolic Syndrome in Type 2 Diabetic Patients at Different Stages of Diabetic Retinopathy
Background. We studied the morphometric and biochemical clusters of metabolic syndrome in patients with type 2 diabetes mellitus (DM) at different stages of diabetic retinopathy (DR). Materials and methods. The study inc...
Orphan Hereditary Syndromes in the Practice of Pediatric Endocrinologist
The lecture presents short phenotypic and genetic characteristics of orphan endocrine syndromes associated with gigantism.
Use of α-Lipoic Acid and Benfotiamine for Correction of Disturbance of Gastric Motor-Evacuation Function in Type 1 Diabetic Patients
The therapeutic effectiveness of α-lipoic acid and benfotiamine in treating symptoms of gastroparesis in type 1 diabetic patients was evaluated. Pathogenetic correlations between increased concentration of peripheral mye...